There is a line Jason Robins will not cross. Even as DraftKings races to build out its prediction markets business, the CEO has been explicit about where the entertainment stops and the ethical problem begins.
“When you start betting on people living, dying wars, it seems to cross a line that I think is not really what we’re looking for.”
Robins made the comment while explaining that DraftKings (NASDAQ:DKNG | DKNG Price Prediction) has internal guidelines prohibiting event contracts on geopolitical situations, citing Iran as a specific example. He pointed to two concerns: the insider risk that comes with politically sensitive information, and a broader ethical judgment that death and war simply do not belong in an entertainment product.
That distinction matters more right now than it ever has, because DraftKings is in the middle of a major strategic pivot into prediction markets.
The Biggest Growth Bet Since PASPA
Robins did not mince words about the opportunity. “Predictions is the most exciting new growth opportunity we have seen since PASPA was struck down in 2018.” He pegs the addressable market at roughly $10 billion in annual gross revenue, with some analyst estimates running as high as $16 billion.
DraftKings launched its Predictions product in December 2025, and early traction has been real. On Super Bowl Sunday, the platform had the second most downloads in its category and delivered three times its prior record for daily trading volume.
The regulatory tailwind is also shifting. The CFTC, under new leadership, has moved from a hands-off posture to what Robins described as a “full-fledged affirmation that this is something the CFTC considers to be firmly under their jurisdiction.” He expects formal guidelines on permissible market types to follow, and says DraftKings will adapt accordingly. Until then, the company is drawing its own lines.
What This Means for the Stock
The business underneath the ethical debate is showing real improvement. DraftKings posted Q4 2025 revenue of roughly $2.0 billion, with adjusted EBITDA of $343 million, four times the prior year figure. Full-year adjusted EBITDA topped $600 million, more than tripling year-over-year.
Yet the stock tells a different story. DKNG is down roughly 31% year-to-date and about 46% over the past year, sitting near $23.82 against an analyst consensus target of $36.17. That gap suggests the market is skeptical about whether prediction market revenue materializes fast enough to justify the valuation. Notably, DraftKings director Harry Sloan purchased 100,000 shares for $2.18 million in February, according to recent filings.
Robins is betting that ethical guardrails and regulatory credibility are not just the right thing to do, but a competitive advantage. In a space where Kalshi and Polymarket are racing to offer markets on nearly anything, DraftKings is positioning itself as the trusted, compliant operator. Whether that restraint wins long-term users or simply cedes market share to less scrupulous competitors remains the central question surrounding DraftKings’ prediction market strategy.
Top Gaining Stocks
Top Losing Stocks